Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma.
- DOI
- 10.1038/s41408-025-01407-5
- Published
- 2025-12-22
- Container
- Blood Cancer J
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-025-01407-5,
title = {Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma.},
author = {Askeland FB and Bugge VH and Rasmussen AM and Lysén A and Haukås E and Moksnes M and Eilertsen AL and Tsykunova G and Eiken BD and Leknes NM and Rolke J and Stavseth V and Samstad E and Hallstensen RF and Szatkowski D and Hansen AA and Nilsen AS and Slørdahl TS and Abdollahi P and Schjesvold F.},
year = {2025},
journal = {Blood Cancer J},
doi = {10.1038/s41408-025-01407-5},
url = {https://doi.org/10.1038/s41408-025-01407-5}
}RIS
TY - JOUR TI - Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma. AU - Askeland FB AU - Bugge VH AU - Rasmussen AM AU - Lysén A AU - Haukås E AU - Moksnes M AU - Eilertsen AL AU - Tsykunova G AU - Eiken BD AU - Leknes NM AU - Rolke J AU - Stavseth V AU - Samstad E AU - Hallstensen RF AU - Szatkowski D AU - Hansen AA AU - Nilsen AS AU - Slørdahl TS AU - Abdollahi P AU - Schjesvold F. PY - 2025 JO - Blood Cancer J DO - 10.1038/s41408-025-01407-5 UR - https://doi.org/10.1038/s41408-025-01407-5 ER -
APA
FB, A., VH, B., AM, R., A, L., E, H., M, M., AL, E., G, T., BD, E., NM, L., J, R., V, S., E, S., RF, H., D, S., AA, H., AS, N., TS, S., P, A., & F., S. (2025). Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma.. Blood Cancer J. https://doi.org/10.1038/s41408-025-01407-5
Source records
- europe-pmc · retrieved 2026-09-26T21:51:36.831Z
- doaj · retrieved 2026-09-26T21:51:36.817Z